Limb-girdle muscular dystrophy 2F, delta-sarcoglycan deficiency (Q86056): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Created a new Item
 
‎Changed label, description and/or aliases in pt-br, en
description / pt-brdescription / pt-br
 
A distrofia muscular de cinturas autossômica recessiva tipo 2F ou delta-sarcoglicanopatia é uma distrofia muscular da cintura escapular (LGMD), que é um grupo de distúrbios caracterizados por fraqueza muscular progressiva, em que a musculatura pélvica ou da cintura escapular está predominantemente ou principalmente envolvida, e é caracterizada por asa escapular e hipertrofia da panturrilha com início entre 2 e 10 anos. O envolvimento cardíaco ocorre em cerca de 20% dos casos.
description / endescription / en
 
Autosomal recessive limb-girdle muscular dystrophy type 2F, or delta-sarcoglycanopathy is a limb girdle muscular dystrophy (LGMD), which is a group of disorders characterised by progressive muscle weakness, in which the pelvic or shoulder girdle musculature is predominantly or primarily involved, and is characterised by scapular winging and calf hypertrophy with onset between 2 and 10 years. Cardiac involvement occurs in about 20% of cases.

Revision as of 11:25, 15 August 2026

Autosomal recessive limb-girdle muscular dystrophy type 2F, or delta-sarcoglycanopathy is a limb girdle muscular dystrophy (LGMD), which is a group of disorders characterised by progressive muscle weakness, in which the pelvic or shoulder girdle musculature is predominantly or primarily involved, and is characterised by scapular winging and calf hypertrophy with onset between 2 and 10 years. Cardiac involvement occurs in about 20% of cases.
Language Label Description Also known as
default for all languages
ID_667751114
    English
    Limb-girdle muscular dystrophy 2F, delta-sarcoglycan deficiency
    Autosomal recessive limb-girdle muscular dystrophy type 2F, or delta-sarcoglycanopathy is a limb girdle muscular dystrophy (LGMD), which is a group of disorders characterised by progressive muscle weakness, in which the pelvic or shoulder girdle musculature is predominantly or primarily involved, and is characterised by scapular winging and calf hypertrophy with onset between 2 and 10 years. Cardiac involvement occurs in about 20% of cases.

      Statements